Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity
Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
Surgical treatment of chronic pancreatitis is challenging in children and especially laparoscopic surgery has been rarely reported, worldwide
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
This new fund is amongst the largest for the sector in India
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Multiples is the first private equity (PE) investor in the company
Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery
Subscribe To Our Newsletter & Stay Updated
